FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Pfizer | Drug Trials | injectable | Amgen | Europe | Cancer

ALSO NOTED: Anadys names new CEO; Pfizer, Amgen gives to candidates; and much more...

Tools

> In the midst of a restructuring, Anadys Pharmaceuticals has named Steve Worland CEO. He had been head of pharmaceuticals. Release

> Amgen may have hit the ropes, but its ranks include some top donors to the presidential campaigns. Of course, a troubled Pfizer also made the top-donor list.  Report

> Bayer and Onyx ended a late-stage trial of Nexavar for liver cancer in order to dispense the therapy to all the volunteers. Nexavar is approved for kidney cancer. Report

> India's Venus Remedies has inked a joint venture with Pharma Match R&D to sell a new generation carbapenem injectable in Europe. Report

And Finally… A slate of presidential candidates will use forums in Iowa next week to discuss cancer research. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Venus Remedies   Onyx Pharmaceuticals   Pfizer   Drug Trials   injectable   Amgen   Europe   Cancer   Bayer Schering   kidney cancer   Anadys Pharmaceuticals   Steve Worland   Nexavar